Curocell Inc. (372320) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Curocell Inc. (372320:KRX), powered by AI.
- Current Price
- ₩34,100
- P/E Ratio
- -11.2
- Market Cap
- 519.2B
- Sector
- Healthcare
What is the Curocell Inc. stock price forecast?
Curocell Inc. is currently trading at ₩34,100. View real-time AI analysis on Alpha Lenz.
What is Curocell Inc. insider trading activity?
View the latest insider trading data for Curocell Inc. on Alpha Lenz.
What is Curocell Inc.'s P/E ratio?
Curocell Inc.'s P/E ratio is -11.2.
Curocell Inc.
KRX · 372320“Curocell Inc. trades at a P/E of -11.2 (undervalued) with modest ROE of -268.6%.”
Ask for details →Company Overview
Curocell Inc. is a biotechnology company focused on the development and commercialization of innovative cell-based therapies. Specializing in CAR-T cell therapy, Curocell utilizes advanced biotechnological practices to target and treat various forms of cancer. The company's primary objective is to harness T-cell engineering to create cutting-edge solutions for patients with limited treatment options. Curocell operates within the healthcare sector, impacting both the biotechnology and pharmaceutical industries through its research and development efforts. With a strong emphasis on precision medicine, Curocell aims to address unmet medical needs by delivering personalized therapeutic solutions. By pioneering advancements in cell therapy technology, Curocell plays a pivotal role in the evolving landscape of cancer treatment, contributing to more effective and targeted therapeutic approaches.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Curocell Inc. trades at a P/E of -11.2 (undervalued) with modest ROE of -268.6%.”
Ask for details →Frequently Asked Questions
Curocell Inc. (ticker: 372320) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 136 employees. Market cap is $519.2B.
The current price is ₩34,100 with a P/E ratio of -11.21x and P/B of 103.32x.
ROE is -268.60%.